Hasegawa Seiki Department
Specialty Division
, Clinical Medicine Seminars
Specialty Division
Thoracic Oncology, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma. 2013/04
2.
Case report
Solitary mediastinal metastasis of hepatocellular carcinoma treated by video-assisted thoracic surgery: report of a case. 2013/11
3.
Original article
Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung. 2014/02
4.
Original article
Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. 2014/06
5.
Introduction
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. 2014/09
6.
Original article
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). 2014/12
7.
Original article
Biallelic germline and somatic mutations in malignant mesothelioma: Multiple mutations in transcription regulators including mSWI/SNF genes. 2015/02
8.
Original article
Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level. 2015/08
9.
Case report
Gene Mutation Analysis in Determining Late Recurrence of Adenocarcinoma of the Lung. 2015/08
10.
Original article
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial) 2015/11
11.
Original article
A Multicenter Feasibility Study of EBUS-TBNA for Potentially Operable Non-Small Cell Lung Cancer: The JMTO LC07-02 Study (UMIN000001280). 2016
12.
Case report
Successful surgical treatment for infectious giant bullae with mediastinal shift: A case report 2016
13.
Introduction
Current surgical strategies for malignant pleural mesothelioma. 2016/08
14.
Original article
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. 2016/11
15.
Case report
A case of atypical type A thymoma variant. 2016/12
16.
Original article
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma. 2016/12
17.
Case report
Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass 2017/01
18.
Original article
Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer. 2018/01
19.
Original article
The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer. 2018/03
20.
Original article
Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. 2018/09
21.
Original article
Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma. 2019/01
22.
Original article
The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy. 2019/11
23.
Original article
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma. 2020/08
24.
Original article
Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening. 2021/01
25.
Original article
Relationship between Physical function and Health Utility in Patients undergoing surgical treatment for Malignant Pleural Mesothelioma 2021/09
26.
Original article
Quality of life and lung function after pleurectomy/decortication for malignant pleural mesothelioma. 2021/10
27.
Original article
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
Surgical treatment for malignant pleural mesothelioma (Oral presentation,Special/Invited Lecture) 2013/04/02
2.
Less invasive techniques and learning curve effects improve the outcome after extrapleural pneumonectomy for malignant pleural mesothelioma (Poster presentation,General Lecture) 2013/05
3.
Combination efficacy of m TOR and MEK inhibitor in malignant pleural mesothelioma(MPM) (Newspaper announcement,General Lecture) 2013/05/31
4.
Biological roles of deletion of PBRM1 and BAP1 in malignant mesotheliomas (Oral presentation,General Lecture) 2013/10/03
5.
Interaction of gene & environment in malignant mesothelioma; BAP1 mutation in familial & sporadic asbestosinduced tumor (Oral presentation,General Lecture) 2013/10/03
6.
Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer (Oral presentation,General Lecture) 2013/10/07
7.
Activation of mTOR signal pathway is associated with prolonged survival in malignant pleural mesothelioma patients (Poster presentation,General Lecture) 2013/10/28
8.
Characteristic Immunophenotype of Solid Subtype Component in Lung Adenocarcinoma (Poster presentation,General Lecture) 2013/10/29
9.
Association of activation of mTOR and MAPK signal pathway is associated with prolonged survival in parient with malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/05/30
Post-recurrence additional chemotherapy is feasible and effective in patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/09/29
12.
A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy / decortication for malignant pleural mesothelioma - Japan mesothelioma interest group (JMIG) 1101 trial- (Poster presentation,General Lecture) 2014/10/21
13.
Diagnostic total parietal pleurectomy for pathologically-undetermined radiological/thoracoscopis TO malignant pleural mesothelioma. (Poster presentation,General Lecture) 2014/10/22
14.
Early results of consecutive 27 patients who underwent pleurectomy / decortication for malignant pleutral mesothelioma (Poster presentation,General Lecture) 2014/10/22
15.
Postoperative chemotherapy after pleurectomy/decortication for malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/10/22
16.
The incidence and risk factors of part site seeding in MPM patients undergoing radical surgery (Poster presentation,General Lecture) 2014/10/22
17.
CD146 expression is associated with prognosis of malignant mesothelioma (Poster presentation,General Lecture) 2014/10/23
18.
Small cell mesothelioma undergone multimodality therapy, report of a case (Poster presentation,General Lecture) 2014/10/23
19.
Current status of malignant mesothelioma in Asia (Oral presentation,Special/Invited Lecture) 2015/04/10
20.
NF2 mutations in malignant pleural mesothelioma synchronous with acoustic neuroma:disease-causing mutation or chance effect? (Oral presentation,General Lecture) 2015/09/09
21.
A case of spindle cell neoplasia in the pleura (Oral presentation,General Lecture) 2015/10/31
22.
Patterns of Detectable Tumor Progression in Patients with Malignant Pleural Mesothelioma with an FDG-PET-Negative T1a Tumor (Poster presentation,General Lecture) 2016/05/02
23.
Evoluation of Surgical Approach in Malignant Pleural Mesothelioma (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/05/03
24.
Induction Chemotherapy Followed by Surgery for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/03
25.
Relationship of PD-L1 Expression and Prognosis in Epithelioid Mesothelioma (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/05/03
26.
The Analysis of the Recurrence of the Patients Who Underwent Surgical Resection for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/03
27.
The Knife or the Needle? 2016/05/03
28.
Clinial, Cytological, and Molecular biological approaches to the diagnosis of early mesothelopma (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/05/29
29.
ESTS-JAPANESE ASSOCIATION OF CHEST SURGERY(JACS) JOINT 2016/05/30
Multiple minute homozygous deletions on 3p21 in malignant mesothelioma (Oral presentation,General Lecture) 2017/09/29
32.
Relationship pulmonary function and physical function at convalescent phase among surgical treatment patients in malignant pleural mesothelioma (Poster presentation,General Lecture) 2019/06/11